Does Sucralfate Help a Hiatal Hernia?

Sucralfate does not fix a hiatal hernia or address the structural problem that causes one, and major gastroenterology guidelines recommend against using it for the reflux that hiatal hernias produce, with one notable exception: pregnancy. The drug works by coating damaged tissue in the digestive tract rather than by reducing acid production, which makes it a poor match for the ongoing mechanical reflux a hiatal hernia creates. That said, there are specific situations where sucralfate plays a real and sometimes underappreciated role for people with hiatal hernias, and the reasons it falls short in most cases are worth understanding.

How a Hiatal Hernia Creates Reflux

A hiatal hernia happens when part of the stomach pushes upward through the opening in the diaphragm where the esophagus passes through. The result is that two structures that normally work together to keep stomach contents from flowing backward into the esophagus get pulled apart. One is the muscular sphincter at the bottom of the esophagus. The other is the diaphragm itself, which squeezes around that sphincter like a second clamp.

When a hernia separates these two barriers, reflux becomes far more likely. Research has shown that patients with a hiatal hernia have a much higher proportion of reflux episodes happening during periods when sphincter pressure drops, compared to patients without a hernia, even when average sphincter pressure is similar between the two groups. The displaced diaphragm appears to be the key factor: it can no longer reinforce the sphincter during moments of low pressure.¹ Both the size of the hernia and the baseline sphincter pressure matter, but hernia size turns out to be the single strongest predictor of how much reflux a person experiences.²

This is important context for understanding sucralfate, because the drug does nothing to reposition the stomach, strengthen the sphincter, or bring the diaphragm back into alignment. The reflux is mechanical, and sucralfate’s strengths lie elsewhere.

What Sucralfate Actually Does

Sucralfate is a mucosal protectant, not an acid suppressor. When it reaches the stomach and upper GI tract, it forms a sticky, viscous coating that binds preferentially to areas where tissue is already damaged. The drug has a chemical affinity for exposed proteins in mucosal lesions, creating a physical barrier over ulcers and erosions.³ It also buffers small amounts of acid, blocks the digestive enzyme pepsin from reaching damaged tissue, and binds bile salts that can irritate the esophageal and gastric lining.³

Because sucralfate is barely absorbed into the bloodstream, it stays in the gut and acts locally. This is both its main advantage (very few systemic side effects) and its main limitation (it doesn’t change the volume or acidity of stomach contents the way proton pump inhibitors do). For a condition like a peptic ulcer, where there’s a defined wound that needs protection while it heals, sucralfate makes intuitive sense. For the chronic, repeated acid exposure that a hiatal hernia produces, it’s trying to put a bandage on a wound that keeps reopening.

What the Guidelines Recommend

The American College of Gastroenterology’s clinical guideline on gastroesophageal reflux disease is blunt on this question. It explicitly recommends against sucralfate for GERD therapy except during pregnancy, calling the recommendation “strong” despite acknowledging a low level of supporting evidence. The guideline notes that limited studies have suggested sucralfate works about as well as older acid-reducing drugs, but there are no head-to-head comparisons against proton pump inhibitors, which are the standard treatment for significant reflux.⁴ The guideline’s summary is essentially that there is little reason to choose sucralfate for reflux outside of pregnancy, given the alternatives available.

This doesn’t mean sucralfate is harmful for people with hiatal hernias. It means the evidence that it helps with their primary symptom, reflux, is thin compared to the evidence for PPIs. For someone whose reflux is mild and infrequent, mucosal protectants taken as needed remain a reasonable option alongside lifestyle changes.⁵ But for the kind of persistent, daily reflux that larger hiatal hernias produce, sucralfate alone is not going to keep up.

Cameron Lesions and the Niche Where Sucralfate Fits

There is one complication of hiatal hernias where sucralfate’s tissue-coating ability becomes genuinely useful: Cameron lesions. These are erosions or small ulcers that develop on the folds of stomach lining right where it gets pinched by the diaphragm. They’re caused by mechanical trauma and possibly reduced blood flow at the pressure point, and they can bleed slowly enough to cause iron-deficiency anemia without any obvious symptoms like vomiting blood.

Cameron lesions occur in a substantial minority of people with hiatal hernias, particularly larger ones. Because these are localized wounds on the mucosal surface, sucralfate’s ability to coat and protect damaged tissue is well suited to helping them heal. In clinical practice, sucralfate is often used alongside a PPI for Cameron lesions. One documented case involved a patient with chronic iron-deficiency anemia from a Cameron lesion who was treated with pantoprazole and sucralfate four times daily for six weeks; at follow-up, her symptoms had resolved and her blood values normalized, though the erosion was still partially visible endoscopically.⁶

If your doctor has told you that you have Cameron lesions or gastric erosions associated with your hiatal hernia, sucralfate is a more targeted and defensible choice than it is for garden-variety reflux. The drug is going after the specific tissue damage rather than trying to control the reflux itself.

Sucralfate Combined with Alginates

One area of recent interest is combining sucralfate with sodium alginate, a compound derived from seaweed that forms a raft-like gel on top of stomach contents. The idea is that the alginate raft physically blocks reflux while sucralfate protects the esophageal lining from whatever acid does get through. A randomized phase 3 trial tested a combined sucralfate-alginate formulation against omeprazole (a PPI) in patients with non-erosive reflux disease or mild erosive disease. The combination was noninferior to omeprazole for heartburn-free days, with about half of days being heartburn-free in both groups. For regurgitation-free days, the sucralfate-alginate group actually did significantly better, with roughly 54% regurgitation-free days compared to about 50% on omeprazole.⁷

This is notable because it shows that sucralfate-based formulations can compete with PPIs when designed thoughtfully, particularly for the regurgitation component of reflux that PPIs handle less well. PPIs reduce the acidity of what comes up, but they don’t stop the mechanical act of reflux itself. For someone with a hiatal hernia who experiences volume reflux, reaching the esophagus as a physical surge of liquid rather than just an acid burn, a barrier-forming approach has a logical advantage. This combination approach is not yet widely available or standardly recommended, but it signals that sucralfate may have a larger role when paired with the right partner.

The Pregnancy Exception

Pregnancy is the one scenario where sucralfate moves from the back bench to a starting position for hiatal hernia-related reflux. Hormonal changes relax the sphincter at the bottom of the esophagus while the growing uterus pushes the stomach upward, a combination that can worsen an existing hiatal hernia or mimic one. Many standard reflux medications raise safety concerns during pregnancy, but sucralfate’s minimal absorption into the bloodstream gives it a clean safety profile. Animal studies have shown no harmful effects on fetal development even at doses far above what humans take, and the FDA classified it as a category B drug for pregnancy.⁸

In the one prospective trial that evaluated sucralfate for pregnancy-related reflux, 90% of women in the sucralfate group experienced relief of heartburn and regurgitation, compared to 43% in the group using lifestyle modifications alone.⁸ That’s only one trial, so the numbers should be taken with some caution, but the direction of the effect is clear. Sucralfate and alginic acid are both considered appropriate options during pregnancy and lactation for reflux that doesn’t respond to antacids and dietary changes.⁹

Drug Interactions You Need to Know About

Because sucralfate stays in the gut and forms a sticky coating, it can trap other medications you take by mouth and prevent them from being absorbed. This is not a minor theoretical concern. Fluoroquinolone antibiotics (like ciprofloxacin and levofloxacin) lose a significant portion of their effectiveness when taken alongside sucralfate.¹⁰ The impact varies for other drug classes, but the general rule is simple: take other medications at least two hours before sucralfate, or the sucralfate may physically block their absorption. Animal research has confirmed that when another medication is given at the same time as sucralfate suspension, absorption can drop dramatically, but separating doses by two hours largely eliminates the problem.¹¹

This timing issue is especially relevant for people with hiatal hernias because they often take other medications, whether PPIs, antacids, or drugs for unrelated conditions. If you’re on multiple medications and your doctor adds sucralfate, you’ll need to plan your dosing schedule carefully. The standard sucralfate dose is taken on an empty stomach, typically an hour before meals, which can create scheduling headaches when you’re also taking a morning PPI and possibly other pills.

Aluminum and Kidney Disease

Sucralfate contains aluminum, and for most people this is irrelevant because the drug is barely absorbed. But in people with impaired kidney function, even the small amount of aluminum that does enter the bloodstream can accumulate over time. Aluminum toxicity has been reported in patients with compromised kidneys who used sucralfate, particularly with long-term use. The risk goes up further if someone is also taking other aluminum-containing products like certain antacids or phosphate binders.¹² If you have chronic kidney disease, sucralfate is generally something to avoid or use only under close monitoring.

Paraesophageal Hernias and When Medication Is Not Enough

Not all hiatal hernias are created equal. The common sliding type, where the stomach junction moves up and down through the diaphragm, accounts for the vast majority of cases and is the type most discussions of reflux medication address. Paraesophageal hernias, where part of the stomach herniates alongside the esophagus and can become trapped above the diaphragm, are rarer and far more serious. These tend to occur in older adults and can cause a mix of reflux symptoms, anemia from mucosal erosions, and breathing difficulties. Acute complications like the stomach twisting on itself are uncommon, estimated at around 1.2% per patient per year, but they can be life-threatening when they do occur.¹³

For paraesophageal hernias, the conversation shifts from which medication to take to whether surgery is necessary. No medication, sucralfate or otherwise, addresses the risk of stomach incarceration or volvulus. If you’ve been told you have a paraesophageal hernia, the question isn’t whether sucralfate will help with reflux symptoms; it’s whether the hernia itself needs to be repaired surgically. Sucralfate might ease symptoms in the interim, particularly if mucosal erosions are present, but it does not substitute for a surgical evaluation.

How Hiatal Hernias Get Diagnosed in the First Place

Many people learn they have a hiatal hernia incidentally, during an endoscopy or imaging study done for another reason. The diagnosis is straightforward when the hernia is large, but smaller hernias are harder to pin down. Standard endoscopy and barium swallow X-rays are reasonably good at detecting hernias larger than about 2 cm, but they struggle with subtler ones because the junction between the esophagus and stomach moves with each swallow and breath.¹⁴

High-resolution manometry, which measures pressure patterns along the esophagus in real time, has emerged as the most accurate method for detecting hiatal hernias. A meta-analysis comparing the three main diagnostic methods found that manometry outperformed both X-ray and endoscopy, particularly in its ability to correctly rule out a hernia when one isn’t present.¹⁵ A separate comparison found that manometry produced far fewer false positives than endoscopy.¹⁶ This matters if you’ve been told you have a small hiatal hernia based on endoscopy alone and are weighing treatment options. The diagnosis might be accurate, or it might be a false positive, and the answer changes what treatment makes sense.

Understanding the reliability of your diagnosis affects whether you pursue any medication at all. If a small hernia was noted casually on an endoscopy but you have minimal symptoms, the appropriate response may well be watchful waiting rather than starting sucralfate, a PPI, or anything else. Confirming the hernia’s size and presence, ideally with manometry if symptoms are unclear, helps avoid treating a problem that may not actually exist.